Radioiodine‐Refractory Differentiated Thyroid Cancer: Definition, Molecular Mechanisms, and Advances in Precision Therapy
ABSTRACT Radioiodine‐refractory differentiated thyroid cancer, defined by loss of responsiveness to ¹³¹I therapy or by heterogeneous iodine uptake, accounts for the majority of thyroid cancer‐related deaths; 10‐year survival is approximately 10% with distant metastases. Its definition is not uniform...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2026-08-01
|
| Seri Bilgileri: | Cancer Innovation |
| Konular: | |
| Online Erişim: | https://doi.org/10.1002/cai2.70078 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|